Search for: "Ariad Pharmaceuticals Inc."
Results 81 - 100
of 103
Sorted by Relevance
|
Sort by Date
4 Sep 2010, 8:29 pm
" Ariad Pharms., Inc. v. [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
1 Apr 2011, 5:17 pm
In Ariad Pharmaceuticals, Inc. [read post]
15 Jun 2014, 6:18 pm
” Takeda at *14 (quoting Ariad Pharms., Inc. v. [read post]
9 Oct 2020, 8:25 am
The answer is that the federal courts over time have misunderstood and misapplied the Supreme Court’s landmark 2006 decision in eBay Inc. v. [read post]
8 Mar 2011, 1:23 pm
Cir. 2010) (en banc) Ariad Pharmaceuticals, Inc. v. [read post]
18 Apr 2017, 6:52 am
See Ariad Pharms., Inc. v. [read post]
20 Mar 2014, 5:34 pm
Barr’s ANDA filing was second to that of Par Pharmaceuticals, Inc. [read post]
1 Nov 2019, 12:30 pm
., Inc. two years earlier. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
22 Aug 2011, 2:00 am
See Ariad Pharmaceuticals, Inc. v. [read post]
22 Aug 2011, 2:00 am
See Ariad Pharmaceuticals, Inc. v. [read post]
24 Oct 2011, 9:36 am
[4] Ariad Pharmaceuticals, Inc. v. [read post]
9 Apr 2015, 11:59 am
Rev. 1571, 1582, 1607 (2009), which mentions -- I thank Josh Walker, Mark Lemley, and the underwriters of the Stanford IP Litigation Clearinghouse for making this research possible-- but does not mention Eolas or Ariad. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
31 Jan 2011, 8:10 am
Kappos, to Ariad Pharmaceuticals v. [read post]
